•  
  •  
  •  
  •  

2023-03-24 01:56:05

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • W S Industries India Ltd approves availing of short term loans
  • SBI completes acquisition of 40% stake of Canara Bank in Commercial Indo Bank LLC
  • Indigenous Casting Technology Pvt Ltd becomes 100% subsidiary of NIBE Ltd
  • R.P.P Infra Projects Wins a New Order Worth INR 104.79 Crores
  • Healthcare Triangle to Participate in ViVE 2023 as Presenter and Sponsor

Keywords Selected:  LIC

Research

  • Mr. Dhiraj Relli, MD & CEO, HDFC Securities, commentary on RBI Monetary Policy
  • Monetary Policy Update - September 2022 - ICICI Direct
  • Views on RBI Monetary Policy - Sep 2022 - HDFC Securities
  • Impact on Rupee by RBI MPC - Sep 2022 - Reliance Securities
  • Acuité Ratings & Research comments on RBI MPC Sep'22
  • Views on Monetary Policy - Sep 2022 - 50bps Hike - YES Securities
  • RBI Monetary Policy - September 2022 - Views from Kotak Mahindra Group
  • Pre RBI Monetary Policy View - Ajit Banerjee, Chief Investment Officer, Shriram Life Insurance
  • RBI Monetary Policy - Can the Housing Market Absorb Another Hike?
  • RBI Policy Preview Sep-22 - MPC likely to raise rates by 50 bps - Acuité Ratings
  • Policy rate hikes by RBI seem unavoidable in the face of global headwinds, inflation : ASSOCHAM
  • Growth broad basing with most sectors operating at pre-pandemic levels: FICCI-IBA Bankers' Survey
  • RBI's repo rate increase of 50 bps - the third in a row in line with our expectations
  • LIC Housing Finance - Q1FY23 Result Update - NII growth may exceed loan accretion - BUY
  • LIC Housing Finance - Q4FY22 Result Update - Fixed rate liabilities could cushion NIM - BUY
  • MPC Minutes: Jun-22: All eyes on inflation - Acuité Ratings
  • RBI frontloads rate hike amid increased inflationary headwinds - Acuité Ratings
  • Monetary Policy June 2022 - Axis MF Views
  • RBI Monetary Policy View - Mr. Dhiraj Relli, MD & CEO, HDFC Securities
  • Monetary Policy - entering the red zone - Anuj Puri, ANAROCK
  • Mr. Murali Ramakrishnan, MD &CEO, South Indian Bank on RBI Monetary Policy
  • Comments on RBI's MPC Policy Jun'22 - Acuité Ratings
  • Views on RBI Monetary Policy - June 2022
  • Life Insurance Corporation of India - IPO - India's Insurance Behemoth; Attractive Valuation

Market Commentary

  • Pre-Monetary Policy View - Jun 2022 - Kotak Mahindra Bank Ltd
  • Geopolitical Risks Take Centre Stage - RBI Projects Lower Growth, Higher Inflation
  • Continuation of RBI's accommodative stance is welcome: FICCI
  • Views of Axis Mutual Fund on RBI Monetary Policy - April 2022
  • Views on RBI Monetary Policy - April, 2022 - Federal Bank
  • Industry Expert Views on Monetary Policy - April, 2022

IPO News

  • Indore Municipal Corporation's Green Bonds lists on National Stock Exchange
  • Blue Jet Healthcare files DRHP for IPO
  • Concord Enviro Systems Ltd gets SEBI approval to raise funds via IPO
  • LIC IPO - Day 5 - Overall Issue Subscribed 1.79 times; Policy holders' portion booked 5.04 times
  • LIC IPO - Day 4 - NII Segment fully subscribed, Overall Issue Subscribed 1.66 times
  • LIC IPO - Day 3 - Overall Issue Subscribed 1.38 times
  • LIC IPO to open on May 4, sets price band at ₹ 902 to ₹ 949 per Equity Share
  • Venus Pipes and Tubes Limited gets SEBI nod for IPO
  • Life Insurance Corporation of India and eMudhra gets Sebi nod for IPO
  • Religare Broking launches 'Pre Apply LIC IPO' app to open DEMAT account & register for upcoming public issues
  • Life Insurance Corporation of India files for biggest Indian IPO

Stock Report

  • UNDP collaborates with Infosys Public Services
  • IRCTC signs MoU with UCADA to provide Helicopter Ticket booking service
  • Lupin receives tentative approval from U.S. FDA for Obeticholic Acid Tablets
  • Sharda Motor Industries Ltd updates on new plant at Chakan
  • Indian Coast Guard to get Advance Light Helicopters MK-III from HAL
  • Glenmark receives acceptance from U.S. FDA for Phase 1/2, first-in-human clinical study of GRC 54276
  • LIC dilutes stake in TIL Ltd
  • Shri Tablesh Pandey appointed as MD of LIC
  • LIC increases stake in Dr. Reddys Laboratories Ltd
  • Brand Concepts Ltd enters into long-term contract with UCB
  • Nazara Technologies Ltd updates on balances of subsidiaries in Silicon Valley Bank
  • Welspun Corp Ltd's subsidiary gets export orders
  • Magellanic Cloud bags an order to service 3,032 ATM sites
  • KNR Constructions Ltd cautions against circulation of unsolicited / unauthorised messages
  • Kimia Biosciences Ltd receives approval of advance authorisation
  • Neogen Chemicals enters into a definitive agreement to acquire 100% stake in BuLi Chemicals India Pvt. Ltd. from Livent
  • VadiBro is Back to Deliver Deliciousness with Vadilal's New Gourmet Natural Flavours
  • Bajaj Finserv gets SEBI license to commence Mutual Fund business
  • LT Foods Ltd allots 27,408,164 shares to SALIC International
  • LIC reduces stake in P I Industries Ltd
  • Sical Logistics Limited allots shares to public shareholders, new promoter
  • CoC approves resolution plan of Shyam Sel and Power Ltd for Mittal Corp Ltd
  • LIC reduces stake in Industrial Investment Trust Ltd
  • Atishay Limited wins order of Rs. 29.85 lakhs

Industry News

  • NTT DATA Payment Services accorded approval by RBI for payment aggregator license
  • LIC of India introduces Dhan Rekha(Plan 863)

Latest Post

  • W S Industries India Ltd approves availing of short term loans
  • SBI completes acquisition of 40% stake of Canara Bank in Commercial Indo Bank LLC
  • Indigenous Casting Technology Pvt Ltd becomes 100% subsidiary of NIBE Ltd
  • R.P.P Infra Projects Wins a New Order Worth INR 104.79 Crores
  • Healthcare Triangle to Participate in ViVE 2023 as Presenter and Sponsor


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
No:AP-172, 2nd Sector, 10th Street, KK Nagar
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-80560-88967
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
West Mambalam, Chennai - 600 033,
Tamil Nadu, India

Disclaimer Copyright © - 2022